Literature DB >> 2659920

Protective immunity in mouse salmonellosis: comparison of smooth and rough live and killed vaccines.

A Muotiala1, M Hovi, P H Mäkelä.   

Abstract

Protective immunity against Salmonella infection was studied in a mouse model. To study specificity of protection we used smooth (O-4,5,12) and rough vaccines; live and killed vaccines of both types were compared. The protection was assessed by enumerating the number of bacteria in the livers, and by following survival of the mice after intravenous challenge with smooth O-4,5,12 bacteria. Passively transferred antibodies induced by the smooth vaccines had a small protective effect and those induced by the rough vaccines no protective effect in this model. Both live vaccines induced long-lasting protective immunity which was much stronger than that mediated by antibodies. Since the live rough vaccine induced protective immunity and contained no O antigen we conclude that the protective immunity induced by it was mainly cell-mediated and directed to other antigens than the O antigen, the target of protective antibodies. Both killed vaccines also induced protective immunity, but this was weaker than that induced by the corresponding live vaccine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659920     DOI: 10.1016/0882-4010(89)90007-7

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

1.  The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing.

Authors:  N M Zirk; S F Hashmi; H K Ziegler
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

3.  A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria.

Authors:  R Puohiniemi; M Karvonen; J Vuopio-Varkila; A Muotiala; I M Helander; M Sarvas
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 4.  New technologies in using recombinant attenuated Salmonella vaccine vectors.

Authors:  Roy Curtiss; Wei Xin; Yuhua Li; Wei Kong; Soo-Young Wanda; Bronwyn Gunn; Shifeng Wang
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

5.  Role of gamma interferon in late stages of murine salmonellosis.

Authors:  A Muotiala; P H Mäkelä
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues.

Authors:  N A Nnalue
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

8.  The Efficacy of a Trivalent Inactivated Salmonella Vaccine Combined with the Live S. Gallinarum 9R Vaccine in Young Layers after Experimental Infections with S. Enteritidis, S. Typhimurium, and S. Infantis.

Authors:  Yosef Daniel Huberman; Melanie Caballero-García; Rober Rojas; Silvia Ascanio; Leandro Hipólito Olmos; Rosana Malena; Jorgelina Lomónaco; Paula Nievas; Paula Chero; Julio Lévano-Gracía; Alfredo Mendoza-Espinoza
Journal:  Vaccines (Basel)       Date:  2022-07-12

9.  Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine.

Authors:  Daniel C Shippy; Amin A Fadl
Journal:  BMC Microbiol       Date:  2012-11-30       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.